NMDAR2A anticorps (pTyr1246)
Aperçu rapide pour NMDAR2A anticorps (pTyr1246) (ABIN2141067)
Antigène
Voir toutes NMDAR2A (GRIN2A) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- pTyr1246
-
Immunogène
- NMDAR2A antibody was raised in Rabbit using synthesized phosphopeptide derived from human NMDA or NR2A/B around the phosphorylation site of Tyr1246,Tyr1252 (N-L-YP-D-I) as the immunogen
-
Isotype
- IgG
-
-
-
-
Indications d'application
- IHC: 1:50-1:100, IF: 1:100-1:500, ELISA: 1:10000
-
Restrictions
- For Research Use only
-
-
-
Concentration
- Lot specific
-
Buffer
- PBS buffer (without Mg2+and Ca2+), pH 7.4, 150 mM NaCl with 0.02 % sodium azide and 50 % glycerol
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot and store at -20 °C
-
-
- NMDAR2A (GRIN2A) (Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2a (GRIN2A))
-
Autre désignation
- NMDAR2A
-
Pathways
- Synaptic Membrane, Regulation of long-term Neuronal Synaptic Plasticity
Antigène
-